Gecina (OTCMKTS:GECFF) Receives $127.00 Average Target Price from Analysts

Gecina (OTCMKTS:GECFFGet Rating) has received a consensus recommendation of “Buy” from the ten ratings firms that are presently covering the company, reports. Three analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $127.00.

GECFF has been the subject of several recent analyst reports. Morgan Stanley decreased their price target on Gecina from €135.00 ($146.74) to €120.00 ($130.43) in a research note on Monday, March 28th. Societe Generale upgraded Gecina from a “hold” rating to a “buy” rating and set a $134.00 price target for the company in a research note on Friday, March 25th. Oddo Bhf downgraded Gecina from an “outperform” rating to a “neutral” rating in a research note on Wednesday, February 9th. Zacks Investment Research upgraded Gecina from a “sell” rating to a “hold” rating in a research note on Tuesday, March 29th. Finally, HSBC upgraded Gecina from a “hold” rating to a “buy” rating in a research note on Thursday, January 27th.

GECFF opened at $114.55 on Wednesday. The stock has a 50-day moving average of $122.65 and a 200-day moving average of $133.81. Gecina has a 52-week low of $114.55 and a 52-week high of $163.00. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.40.

Gecina Company Profile (Get Rating)

Gecina operates innovative and sustainable living spaces. The Group owns, manages and develops Europe's leading office portfolio, with nearly 97% located in the Paris Region, and a portfolio of residential assets and student residences, with over 9,000 apartments. These portfolios are valued at 20 billion euros at end-June 2020.

Further Reading

Analyst Recommendations for Gecina (OTCMKTS:GECFF)

Receive News & Ratings for Gecina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gecina and related companies with's FREE daily email newsletter.